FORT LAUDERDALE, FL / ACCESS Newswire / February 18, 2025 / ZEO ScientifiX, Inc. ("ZEO" or the "Company") (OTCQB:ZEOX), a clinical-stage biopharmaceutical company focused on the research and development of innovative biological therapeutics for the treatment of degenerative diseases and regenerative medicine and the development and sales of biologic products used in topical aesthetic applications, today announced that it has appointed Peter A. M. Everts, Ph.D.
FORT LAUDERDALE, FL / ACCESSWIRE / November 13, 2024 / ZEO ScientifiX, Inc. ("ZEO" or the "Company") (OTCQB:ZEOX), a South Florida-based clinical-stage biopharmaceutical company, announced it has partnered with its affiliate Exotropin, LLC, a privately-held company that produces cosmetics, nutraceuticals, and other consumer products to design and deliver a hair growth solution for people who have considered hair transplant surgery. The companies will introduce their first planned collaborative product, ZEO HAIR GROW™ Powered By Exotropin™, at the Medical Aesthetics Professionals (MAP) meeting being held in Scottsdale, Arizona, from November 14 - 16, 2024.
Zeo Energy Acquires Substantially All of Lumio's Assets Transaction is Expected to Position Zeo Energy for Enhanced Market Presence and Expansion NEW PORT RICHEY, Fla. and LEHI, Utah, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Zeo Energy Corp. (Nasdaq: ZEO) ( “Zeo Energy”, or the “Company”), a leading Florida-based provider of residential solar and energy efficiency solutions, today announced that it has completed the acquisition of substantially all of the assets (the “Sale Transaction”) of Lumio Holdings, Inc. (“Lumio”), another residential solar company.
Events Hosted By ZEO ScientifiX Offer Providers Practical Business Tools Along With Science And Research Insights FORT LAUDERDALE, FL / ACCESSWIRE / October 15, 2024 / ZEO ScientifiX, Inc. ("ZEO" or the "Company") (OTCQB:ZEOX), a South Florida-based clinical-stage biopharmaceutical company, announced the launch of a monthly educational event for healthcare providers and members of their staff. The in-person events, titled "The Future of Biologic Medicine: Expert-Led Discussions and Case Studies," provide physicians the opportunity to learn about the science of regenerative medicine, with special emphasis on current research efforts surrounding the therapeutic potential of extracellular vesicles and innovative autologous biologics.
Physicians Group, LLC's Network Of Clinics And Diverse Patient Population Will Provide ZEO With Exclusive Research-Based Opportunities FORT LAUDERDALE, FL / ACCESSWIRE / October 1, 2024 / ZEO ScientifiX, Inc. ("ZEO" or the "Company") (OTCQB:ZEOX), a clinical-stage biopharmaceutical company, announced that it has recently partnered with Physicians Group, LLC ("Physicians Group"), a multi-state provider organization that together with its affiliated entities operates 75 clinics and employees over 750 clinical personnel treating between 1,500 - 2,000 patients per month, many of whom seek care for musculoskeletal conditions. ZEO ScientifiX Logo ZEO and Physicians Group intend to collaborate on future clinical trials that will focus on certain health indications commonly seen by Physicians Group's doctors whereby ZEO's products demonstrate greater therapeutic benefit than currently available treatments.
NEW PORT RICHEY, Fla., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Zeo Energy Corp. (Nasdaq: ZEO) (“Zeo”, “Zeo Energy”, or the “Company”), a leading Florida-based provider of residential solar and energy efficiency solutions, is confirmed to present at the 2024 Annual Gateway Conference , which is being held September 4-5, at the Four Seasons Hotel in San Francisco, CA.
NEW PORT RICHEY, Fla., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Zeo Energy Corp. (Nasdaq: ZEO) (“Zeo”, “Zeo Energy”, or the “Company”), a leading Florida-based provider of residential solar and energy efficiency solutions, today reported financial results for the second quarter and six months ended June 30, 2024.